Steven Cohen's Point72 Asset Management has liquidated its entire position in Lantheus Holdings (LNTH), according to its latest quarterly disclosure. The firm sold off its 629,810 shares, which were valued at approximately $69.87 million at the end of the second quarter of 2026.

This trade was revealed in a 13F filing, which details institutional investment managers' holdings as of September 30, 2026. These filings are released with a delay, offering a retrospective view of a firm's portfolio changes from the previous quarter. Lantheus is a radiopharmaceutical company focused on products for medical imaging and diagnostics. In August 2026, the company entered a definitive agreement to be acquired by Curium in a deal valued at up to approximately $8.0 billion.